Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2021

Sep 24, 2021

35119_dirs_2021-09-24_92aaf682-dbbd-49e2-98c2-eb3a4dee74c7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2021-09-23

Reporting Person: RUBIN ROBERT J. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-23 Stock Option (Right to Buy) $1.03 A 29126 Acquired 2031-09-22 Common Stock (29126) Direct

Footnotes

F1: The stock option vests ratably on each of December 23, 2021, March 23, 2022, June 23, 2022 and September 23, 2022.